June 24, 2025
A twice-a-year shot to prevent HIV being dubbed a “wonder drug” by some could be coming to Canada as soon as next year, though the company behind it says it could still take some time before the general population could access it.
Gilead Canada confirmed to Global News that it had submitted lenacapavir for pre-exposure prophylaxis (PrEP) use as a new injectable drug to Health Canada in April of this year and it had been accepted by the agency for review this month.
It said it anticipates the evaluation of the drug would be complete sometime in mid-2026.
Global News has inquired with Health Canada about potential approval time as well as a timeline for the approval process.
Canadian health-care experts and advocates for HIV prevention say the Gilead drug is a “monumental advance.”
Read more: https://globalnews.ca/news/11254654/hiv-prevention-shot-canada/